KATRINA MAXWELL: Open Payments
NPI 1851724272 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,597 in 102 payments from 17 companies in 2025. Trend: 2023 $80 · 2024 $1,849 · 2025 $1,597
Food & beverage: $1,597
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $308 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $210 |
| Neurocrine BioSciences, Inc. | 11 | $162 |
| Teva Pharmaceuticals USA, Inc. | 8 | $152 |
| Alkermes, Inc. | 8 | $151 |
| Janssen Pharmaceuticals, Inc | 11 | $150 |
| Otsuka America Pharmaceutical, Inc. | 5 | $103 |
| Lundbeck LLC | 4 | $94 |
| Axsome Therapeutics, Inc. | 3 | $74 |
| Vanda Pharmaceuticals Inc. | 3 | $45 |
Products named: VRAYLAR, CAPLYTA, REXULTI, INGREZZA, SPRAVATO, ARISTADA, UZEDY, Auvelity.
Industry payments across SC — which companies pay providers there.
